Publikationsverzeichnis
| Mann J, Runge S, Schell C, Gräwe K, Thoulass G, Lao J, Ammann S, Grün S, König C, Berger SA, Hild B, Aichele P, Rosshart SP, Ehl S. The Microbiome Modifies Manifestations of Hemophagocytic Lymphohistiocytosis in Perforin-Deficient Mice. Eur J Immunol. 2024 Nov 16:e202451061. doi: 10.1002/eji.202451061. Online ahead of print. |
| de Castro T, Welland S, Jochheim L, Leyh C, Shmanko K, Finkelmeier F, Jeliazkova P, Jefremow A, Gonzalez-Carmona MA, Kandulski A, Roessler D, Ben Khaled N, Enssle S, Venerito M, Fründt TW, Schultheiß M, Djanani A, Pangerl M, Maieron A, Wirth TC, Marquardt JU, Greil R, Fricke C, Günther R, Schmiderer A, Bettinger D, Wege H, Scheiner B, Müller M, Strassburg CP, Siebler J, Ehmer U, Waidmann O, Weinmann A, Pinter M, Lange CM, Saborowski A, Vogel A. Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort. Hepatol Commun. 2024 Nov 4;8(11):e0562. |
| Elurbide J, Colyn L, Latasa MU, Uriarte I, Mariani S, Lopez-Pascual A, Valbuena E, Castello-Uribe B, Arnes-Benito R, Adan-Villaescusa E, Martinez-Perez LA, Azkargorta M, Elortza F, Wu H, Krawczyk M, Schneider KM, Sangro B, Aldrighetti L, Ratti F, Casadei Gardini A, Marin JJG, Amat I, Urman JM, Arechederra M, Martinez-Chantar ML, Trautwein C, Huch M, Cubero FJ, Berasain C, G Fernandez-Barrena M, Avila MA. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma. Gut. 2024 Sep 11:gutjnl-2024-332998. doi: 10.1136/gutjnl-2024-332998. Online ahead of print. |
| Berg T, Aehling NF, Bruns T, Welker MW, Weismüller T, Trebicka J, Tacke F, Strnad P, Sterneck M, Settmacher U, Seehofer D, Schott E, Schnitzbauer AA, Schmidt HH, Schlitt HJ, Pratschke J, Pascher A, Neumann U, Manekeller S, Lammert F, Klein I, Kirchner G, Guba M, Glanemann M, Engelmann C, Canbay AE, Braun F, Berg CP, Bechstein WO, Becker T, Trautwein C; Collaborators. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV). Z Gastroenterol. 2024 Sep;62(9):1397-1573. |
| Fontes A, Pierson H, Bierła JB, Eberhagen C, Kinschel J, Akdogan B, Rieder T, Sailer J, Reinold Q, Cielecka-Kuszyk J, Szymańska S, Neff F, Steiger K, Seelbach O, Zibert A, Schmidt HH, Hauck SM, …, Lutsenko S, Zischka H. Copper impairs the intestinal barrier integrity in Wilson disease. Metabolism. 2024 Sep;158:155973. |
| Abu Sabbah T, Theurer S, Baba HA, Lueong S, Rashidi-Alavijeh J, Hilser T, Zaun Y, Metzenmacher M, Pogorzelski M, Virchow I, Pretzell I, Kostbade K, Treckmann J, Wiesweg M, Schuler M, Kasper S, Zaun G. PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors. Eur J Cancer. 2024 Oct;210:114268. |
| Krupa Ł, Smyk W, Staron R, Niemiec E, Jadwisiak A, Milkiewicz P, Żorniak M, Krawczyk M. Quality of Life and Clinical Outcomes of Endosonography-Guided Biliary Drainage in Patients with Malignant Biliary Obstruction: A Single-Center, Prospective Analysis. J Palliat Med. 2024 Aug 2. doi: 10.1089/jpm.2024.0084. Online ahead of print. |
| Knaup I, Kramann R, Sasula MJ, Mack P, Bastos Craveiro R, Niederau C, Coenen F, Neuss S, Jankowski J, Wolf M. TNF reduces osteogenic cell fate in PDL cells at transcriptional and functional levels without alteration of periodontal proliferative capacity. J Orofac Orthop. 2024 Aug 2. doi: 10.1007/s00056-024-00541-2. Online ahead of print. |
| Sapuk A, Steinhoff L, Huenninghaus K, Willuweit K, Rashidi Alavijeh J, Hild B, Asar L, Schmidt HH, Schramm C. Long-Term Treatment with Bulevirtide in Patients with Chronic Hepatitis D and Advanced Chronic Liver Disease. Can J Gastroenterol Hepatol. 2024 Jul 23;2024:2364031. |
| Himmelsbach V, Jeschke M, Lange CM, Scheiner B, Pinter M, Sinner F, Venerito M, Queck A, Trojan J, Waidmann O, Finkelmeier F. Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial. Cancers (Basel). 2024 Jul 3;16(13):2442. |
| Fischer AK, Baba H, Lainka E, Kälsch J, Müller M, Zens U, Büttner R, Fischer HP. Rapid development of pseudo-ground-glass bodies in liver transplants. Histopathology. 2024 Jul;85(1):190-192. |
| Timmer A, Neuser J, de Sordi D, …, Bokemeyer A, Preiß JC, Otto-Sobotka F, Kaltz B, Sander C, Kruis W. Integrating the Patient Perspective to Validate a Measure of Disease Severity in Inflammatory Bowel Disease: Online Survey of Patients and Their Physicians. Inflamm Bowel Dis. 2024 Jun 29:izae127. doi: 10.1093/ibd/izae127. Online ahead of print. |
| Mertens JE, Bömmer MTC, Regier MB, Gabriëls G, Pavenstädt H, Grünewald I, Horvath J, Trebicka J, Schmidt H, Schlevogt B. Liver Injury after Selective Androgen Receptor Modulator Intake: A Case Report and Review of the Literature. Z Gastroenterol. 2024 Jun;62(6):935-943. |
| Zensen S, Bücker A, Meetschen M, Haubold J, Opitz M, Theysohn JM, Schramm S, Jochheim L, Kasper S, Forsting M, Schaarschmidt BM. Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022. Eur Radiol. 2024 May;34(5):3322-3330. |
| Overbeek KA, Poulsen JL, …, Kahraman A, …, Löhr JM, Rosendahl J; PrescrAIP Study Group. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment. Clin Gastroenterol Hepatol. 2024 May;22(5):994-1004.e10. |
| Sandmann L, Wedemeyer H, Deterding K. Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D-Authors‘ reply. Aliment Pharmacol Ther. 2024 May;59(9):1160-1161. |
| Weiand M, Sandfort V, Nadzemova O, Schierwagen R, Trebicka J, Schlevogt B, Kabar I, Schmidt H, Zibert A. Comparative analysis of SEC61A1 mutant R236C in two patient-derived cellular platforms. Sci Rep. 2024 Apr 25;14(1):9506. |
| Keshoofi P, Schindler P, Rennebaum F, Cordes F, Morgul H, Wildgruber M, Heinzow HS, Pascher A, Schmidt HH, Hüsing-Kabar A, Praktiknjo M, Trebicka J, Seifert LL. Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis. BMC Gastroenterol. 2024 Apr 25;24(1):145. |
| Ben Khaled N, Möller M, Jochheim LS, Leyh C, Ehmer U, Böttcher K, Pinter M, Balcar L, Scheiner B, Weich A, Leicht HB, Zarka V, Ye L, Schneider J, Piseddu I, Öcal O, Rau M, Sinner F, Venerito M, Gairing SJ, Förster F, Mayerle J, De Toni EN, Geier A, Reiter FP. Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events. JHEP Rep. 2024 Apr 8;6(6):101065. |
| Buechter M, Günther AM, Manka P, Gerken G, Kahraman A. Factors Positively Correlated with Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B. J Pers Med. 2024 Apr 5;14(4):390. |
| Leyh C, Coombes JD, Schmidt HH, Canbay A, Manka PP, Best J. MASLD-Related HCC-Update on Pathogenesis and Current Treatment Options. J Pers Med. 2024 Mar 30;14(4):370. |
| Konstantis G, Tsaousi G, Pourzitaki C, Kasper-Virchow S, Zaun G, Kitsikidou E, Passenberg M, Tseriotis VS, Willuweit K, Schmidt HH, Rashidi-Alavijeh J. Identification of Key Genes Associated with Tumor Microenvironment Infiltration and Survival in Gastric Adenocarcinoma via Bioinformatics Analysis. Cancers (Basel). 2024 Mar 26;16(7):1280. |
| Papaefthymiou A, Gkolfakis P, Basiliya K, Facciorusso A, Ramai D, Gerges C, Tziatzios G, Phillpotts S, Webster GJ. Performance and safety of percutaneous cholangioscopy: a systematic review and meta-analysis. Ann Gastroenterol. 2024 Mar-Apr;37(2):225-234. |
| Lwin MW, Cheng CY, Calderazzo S, Schramm C, Schlander M. Would initiating colorectal cancer screening from age of 45 be cost-effective in Germany? An individual-level simulation analysis. Front Public Health. 2024 Feb 21;12:1307427. |
| Liang Y, Luo X, Schefczyk S, Muungani LT, Deng H, Wang B, Baba HA, Lu M, Wedemeyer H, Schmidt HH, Broering R. Hepatitis B surface antigen expression impairs endoplasmic reticulum stress-related autophagic flux by decreasing LAMP2. JHEP Rep. 2024 Jan 28;6(4):101012. |
| Muñoz-Restrepo AM, Navas MC, Daza J, Girala M, Ridruejo E, Gerken G, Teufel A. Prevention in Hepatology. J Pers Med. 2024 Jan 23;14(2):132. |
| Stüben BO, Hoyer DP, Radunz S, Saner F, Schmidt H, Baba HA, Treckmann JW, Mazilescu LI. Idiosyncratic Drug-Induced Liver Injury in a Healthy Patient following PCSK9-Inhibitor Injection. Case Reports Hepatol. 2024 Jan 11;2024:5556907. |
| Sandmann L, Degasperi E, Port K, Aleman S, Wallin JJ, Manuilov D, Da BL, Cornberg M, Lampertico P, Maasoumy B, Wedemeyer H, Deterding K. Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection. Aliment Pharmacol Ther. 2024 Mar;59(6):752-761. |
| Overbeek KA, Poulsen JL, …, Kahraman A, …, Beuers U, Lo Hr JM, Rosendahl J; of the PrescrAIP Study Group. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment. Clin Gastroenterol Hepatol. 2024 May;22(5):994-1004.e10. |
| Schramm C, Sapuk A, Hoyer D, Radünz S, Schmidt H. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis – a retrospective cohort study. Z Gastroenterol. 2024 Jan;62(1):37-42. |
| Schefczyk S, Luo X, Liang Y, Hasenberg M, Walkenfort B, Trippler M, Schuhenn J, Sutter K, Lu M, Wedemeyer H, Schmidt HH, Broering R. Tg1.4HBV-s-rec mice, a crossbred hepatitis B virus-transgenic model, develop mild hepatitis. Sci Rep. 2023 Dec 20;13(1):22829. |
| Stahl Y, Kabar I, Heinzow H, Maasoumy B, Bremer B, Wedemeyer H, Schmidt HH, Pietschmann T, Schlevogt B, Behrendt P. Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing. Emerg Microbes Infect. 2023 Dec;12(2):2251598. |
| Vollmer-Raschdorf S, Rashidi-Alavijeh J, Voigt S, Hengel H, Borchardt B, Huzly D, Hüßler EM, In der Schmitten J, Halenius A, Willuweit K, Botzenhardt S, Trilling M, Boettler T, Dehnen D. Tiza-Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study. BMJ Open. 2023 Nov 2;13(11):e074461. |
| Rennebaum F, Demmig C, Schmidt HH, Vollenberg R, Tepasse PR, Trebicka J, Gu W, Ullerich H, Kabar I, Cordes F. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study. Int J Mol Sci. 2023 Oct 21;24(20):15431. |
| Konstantis G, Tsaousi G, Pourzitaki C, Kitsikidou E, Magouliotis DE, Wiener S, Zeller AC, Willuweit K, Schmidt HH, Rashidi-Alavijeh J. Efficacy of Granulocyte Colony-Stimulating Factor in Acute on Chronic Liver Failure: A Systematic Review and Survival Meta-Analysis. J Clin Med. 2023 Oct 16;12(20):6541. |
| Konstantis G, Tsaousi G, Kitsikidou E, Zacharoulis D, Pourzitaki C. The Immunomodulatory Effect of Various Anaesthetic Practices in Patients Undergoing Gastric or Colon Cancer Surgery: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Clin Med. 2023 Sep 18;12(18):6027. |
| Grapatsas K, Dörr F, Menghesha H, Schuler M, Grünwald V, Bauer S, Schmidt HH, Lang S, Kimmig R, Kasper S, Baldes N, Bölükbas S. New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases. Cancers (Basel). 2023 Sep 1;15(17):4355. |
| Luo X, Zhang R, Schefczyk S, Liang Y, Lin SS, Liu S, Baba HA, Lange CM, Wedemeyer H, Lu M, Broering R. Nuclear translocation of YAP drives BMI-associated hepatocarcinogenesis in hepatitis B virus infection. Liver Int. 2023 Sep;43(9):2002-2016. |
| Jeschke M, Ludwig JM, Leyh C, Pabst KM, Weber M, Theysohn JM, Lange CM, Herrmann K, Schmidt HH, Jochheim LS. Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab. Cancers (Basel). 2023 Aug 26;15(17):4274. |
| Jochheim L, Jochheim D, Habenicht L, Herner A, Ulrich J, Wiessner J, Heilmaier M, Rasch S, Schmid RM, Lahmer T, Mayr U. Adjunctive Hydrocortisone Improves Hemodynamics in Critically Ill Patients with Septic Shock: An Observational Study Using Transpulmonary Thermodilution. J Intensive Care Med. 2023 Aug;38(8):717-726. |
| Staudacher JJ, Backes M, Bettinger D, Blüthner E, Dietz-Fricke C, …, Willuweit K, Yaqubi K, Zeidler C, Schlosser S; für die universitäre JuGa. Positionspapier „Universitäre Karrierewege“. Z Gastroenterol. 2023 Aug;61(8):997-999. |
| Domouchtsidou A, Beckmann F, Marenbach B, Mueller SP, Best J, Herrmann K, Horn PA, Barsegian V, Lindemann M. In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival. Cancers (Basel). 2023 Aug 11;15(16):4055. |
| Kinast V, Andreica I, Ahrenstorf G, Gömer A, Elsner C, Schlienkamp S, Schrader JA, Klöhn M, Ulrich RG, Broering R, Vondran FWR, Todt D, Behrendt P, Dittmer U, Hamprecht A, Witte T, Baraliakos X, Steinmann E. Janus kinase-inhibition modulates hepatitis E virus infection. Antiviral Res. 2023 Sep;217:105690. |
| Matthiessen C, Glaubitz L, Lucht S, Kälsch J, Luedde T, Erbel R, Stang A, Schmidt B, Friedman SL, Canbay A, Bechmann LP, Hoffmann B. Long-term exposure to air pollution and prevalent nonalcoholic fatty liver disease. Environ Epidemiol. 2023 Aug 31;7(5):e268. |
| Kreimeyer H, Vogt K, Götze T, Best J, Götze O, Weigt J, Kahraman A, Özçürümez M, Kälsch J, Syn WK, Sydor S, Canbay A, Manka P. Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis. J Pers Med. 2023 Jul 24;13(7):1180. |
| Zurloh M, Goetz M, Herold T, Treckmann J, Markus P, Schumacher B, Albers D, Rink A, Rosery V, Zaun G, Kostbade K, Pogorzelski M, Ting S, Schmidt H, Stiens R, Wiesweg M, Schuler M, Kasper S, Virchow I. Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting. J Cancer Res Clin Oncol. 2023 Nov;149(14):12903-12912. |
| Schwertheim S, Alhardan M, Manka PP, Sowa JP, Canbay A, Schmidt HH, Baba HA, Kälsch J. Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels. J Pers Med. 2023 Jul 18;13(7):1152. |
| Agarwal B, Cañizares RB, Saliba F, …, Schmidt H, Carbonell-Asins JA, Arroyo V, Fernandez J, Mitzner S, Jalan R. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure. J Hepatol. 2023 Jul;79(1):79-92. |
| Hild B. [The microbiome and metabolic syndrome: is this a chicken-or-egg problem?]. Inn Med (Heidelb). 2023 Jul;64(7):649-654. |
| Watanabe M, Grafe H, Theysohn J, Schaarschmidt B, Ludwig J, Jochheim L, Jeschke M, Schmidt H, Fendler WP, Moraitis A, Herrmann K, Pomykala KL, Weber M. Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90Y Glass Microspheres. J Nucl Med. 2023 Jul;64(7):1102-1108. |
| Pabst KM, Trajkovic-Arsic M, Cheung PFY, Ballke S, Steiger K, Bartel T, Schaarschmidt BM, Milosevic A, Seifert R, Nader M, Kessler L, Siveke JT, Lueckerath K, Kasper S, Herrmann K, Hirmas N, Schmidt HH, Hamacher R, Fendler WP. Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma. J Nucl Med. 2023 Jul;64(7):1049-1055. |
| Roessler D, Öcal O, Philipp AB, Markwardt D, Munker S, Mayerle J, Jochheim LS, Hammer K, Lange CM, Geier A, Seidensticker M, Reiter FP, De Toni EN, Ben Khaled N. Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study. J Cancer Res Clin Oncol. 2023 Jul;149(7):3065-3073. |
| Gillessen J, Reuken P, Hunyady PM, Reichert MC, Lothschütz L, Finkelmeier F, Nowka M, Allo G, Kütting F, Bürger M, Nierhoff D, Steffen HM, Schramm C. Evaluation of Ultrasound-based Surveillance for Hepatocellular Carcinoma in Patients at Risk: Results From a German Multicenter Retrospective Cohort Study. J Clin Transl Hepatol. 2023 Jun 28;11(3):626-637. |
| Buechter M, Dorn D, Möhlendick B, Siffert W, Baba HA, Gerken G, Kahraman A. Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis-The 20-Year Experience of a High-Volume Tertiary Center. J Clin Med. 2023 Jun 21;12(13):4192. |
| Bokemeyer A, Buskermolen J, Ketelhut S, Tepasse PR, Vollenberg R, Trebicka J, Schmidt HH, Vieth M, Bettenworth D, Kemper B. Quantitative Phase Imaging Using Digital Holographic Microscopy to Assess the Degree of Intestinal Inflammation in Patients with Ulcerative Colitis. J Clin Med. 2023 Jun 15;12(12):4067. |
| Reissig TM, Tzianopoulos I, Liffers ST, Rosery VK, Guyot M, Ting S, Wiesweg M, Kasper S, Meister P, Herold T, Schmidt HH, Schumacher B, Albers D, Markus P, Treckmann J, Schuler M, Schildhaus HU, Siveke JT. Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer. ESMO Open. 2023 Jun;8(3):101539. |
| Schrader JA, Burkard TL, Brüggemann Y, Gömer A, Meister TL, Fu RM, Mehnert AK, Dao Thi VL, Behrendt P, Durantel D, Broering R, Vondran FWR, Todt D, Kinast V, Steinmann E. EGF receptor modulates HEV entry in human hepatocytes. Hepatology. 2023 Jun 1;77(6):2104-2117. |
| Alatzides GL, Haubold J, Steinberg HL, Koitka S, Parmar V, Grueneisen J, Zeller AC, Schmidt H, Theysohn JM, Li Y, Nensa F, Schaarschmidt BM. Adipopenia in body composition analysis: a promising imaging biomarker and potential predictive factor for patients undergoing transjugular intrahepatic portosystemic shunt placement. Br J Radiol. 2023 Jun 1;96(1146):20220863. |
| Niesert H, Meier A, Kabar I, Schmidt H, Lenze F, Bokemeyer A. Balloon enteroscopy-assisted endoscopic retrograde cholangiography and rendezvous procedures in patients with altered gastrointestinal anatomy. Scand J Gastroenterol. 2023 Jun;58(6):693-699. |
| Du Y, Khera T, Liu Z, Tudrujek-Zdunek M, Dworzanska A, Cornberg M, Xu CJ, Tomasiewicz K, Wedemeyer H. Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection. Biomedicines. 2023 May 25;11(6):1529. |
| Lutz M, Grünewald I, Lenze F, Heinzow H, Ullerich H, Kabar I, Schmidt HH, Tepasse PR. Unmasking of Metamizole-Induced Liver Injury by Simultaneous Development of Characteristic Agranulocytosis. Curr Drug Saf. 2023;18(3):404-412 |
| Schefczyk S, Luo X, Liang Y, Trippler M, Lu M, Wedemeyer H, Schmidt HH, Broering R. Poly(I:C) Induces Distinct Liver Cell Type-Specific Responses in Hepatitis B Virus-Transgenic Mice In Vitro, but Fails to Induce These Signals In Vivo. Viruses. 2023 May 19;15(5):1203. |
| Saner FH, Frey A, Stüben BO, Hoyer DP, Willuweit K, Daniel M, Rashidi-Alavieh J, Treckmann JW, Schmidt HH. Transplantation for Primary Sclerosing Cholangitis: Outcomes and Recurrence. J Clin Med. 2023 May 11;12(10):3405. |
| Konstantis G, Efstathiou S, Pourzitaki C, Kitsikidou E, Germanidis G, Chourdakis M. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria. Clin Nutr. 2023 May;42(5):800-809. |
| Bokemeyer A, Lenze F, Stoica V, Selcuk Sensoy T, Huesing-Kabar A, Kabar I, Schmidt H, Ullerich H. Utility of Digital Single-operator Video Cholangioscopy for the Endoscopic Management of Biliary Complications After Liver Transplantation-A Single-center Experience. Transplantation. 2023 Apr 1;107(4):925-932. |
| Langer MM, Sichelschmidt S, Bauschen A, Bornemann L, Guckenbiehl S, Gunzer M, Lange CM. Pathological neutrophil migration predicts adverse outcomes in hospitalized patients with liver cirrhosis. Liver Int. 2023 Apr;43(4):896-905. |
| Dietz-Fricke C, Tacke F, Zöllner C, Demir M, Schmidt HH, Schramm C, Willuweit K, Lange CM, Weber S, Denk G, Berg CP, Grottenthaler JM, Merle U, Olkus A, Zeuzem S, Sprinzl K, Berg T, van Bömmel F, Wiegand J, Herta T, Seufferlein T, Zizer E, Dikopoulos N, Thimme R, Neumann-Haefelin C, Galle PR, Sprinzl M, Lohse AW, Schulze Zur Wiesch J, Kempski J, Geier A, Reiter FP, Schlevogt B, Gödiker J, Hofmann WP, Buggisch P, Kahlhöfer J, Port K, Maasoumy B, Cornberg M, Wedemeyer H, Deterding K. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients. JHEP Rep. 2023 Mar 15;5(4):100686. |
| Passenberg M, Authorsen-Grudmann R, Frey A, Korth J, Zmudzinski J, Anastasiou OE, Möhlendick B, Schmidt H, Rashidi-Alavijeh J, Willuweit K. Durability of Immune Response after Application of a Third Dose of SARS-CoV-2 Vaccination in Liver Transplant Recipients. Vaccines (Basel). 2023 Mar 2;11(3):572. |
| Schlevogt B, Schlieper V, Krader J, Schröter R, Wagner T, Weiand M, Zibert A, Schmidt HH, Bergmann C, Nedvetsky PI, Krahn MP. A SEC61A1 variant is associated with autosomal dominant polycystic liver disease. Liver Int. 2023 Feb;43(2):401-412. |
| Le-Trilling VTK, Ebel JF, Baier F, Wohlgemuth K, Pfeifer KR, Mookhoek A, Krebs P, Determann M, Katschinski B, Adamczyk A, Lange E, Klopfleisch R, Lange CM, Sokolova V, Trilling M, Westendorf AM. Acute cytomegalovirus infection modulates the intestinal microbiota and targets intestinal epithelial cells. Eur J Immunol. 2023 Feb;53(2):e2249940. |
| Rashidi-Alavijeh J, Nuruzade N, Frey A, Huessler EM, Hörster A, Zeller AC, Schütte A, Schmidt H, Willuweit K, Lange CM. Implications of anaemia and response to anaemia treatment on outcomes in patients with cirrhosis. JHEP Rep. 2023 Jan 28;5(4):100688 |
| Langer MM, Bauschen A, Guckenbiehl S, Klauss S, Lutz T, Denk G, Zwanziger D, Moeller LC, Lange CM. Evolution of non-thyroidal illness syndrome in acute decompensation of liver cirrhosis and acute-on-chronic liver failure. Front Endocrinol (Lausanne). 2023 Jan 23;14:1104388. |
| Cheng CY, Calderazzo S, Schramm C, Schlander M. Modeling the Natural History and Screening Effects of Colorectal Cancer Using Both Adenoma and Serrated Neoplasia Pathways: The Development, Calibration, and Validation of a Discrete Event Simulation Model. MDM Policy Pract. 2023 Jan 19;8(1):23814683221145701. |
| Bergquist A, Weismüller TJ, Levy C, …, Wedemeyer H, …, Bündgens B, …, Färkkilä M, Lenzen H; International PSC Study Group. Impact on follow-up strategies in patients with primary sclerosing cholangitis. Liver Int. 2023 Jan;43(1):127-138. |
| Katsounas A, Lütkes P, Canbay A, Gerken G. [Health economic evaluation of an internal medicine intermediate care unit (IMC) with gastroenterological focus at a maximum care university hospital – Evaluating the Profitability of Intermediate Care (IMC) in modern University Hospital Gastroenterology]. Z Gastroenterol. 2023 Jan;61(1):37-49. |
| Virchow I, Treckmann JW, Prasnikar N, Linden G, Markus P, Schumacher B, Albers D, Herold T, Ting S, Schmidt H, Radunz S, Wiesweg M, Siveke J, Schuler M, Kasper S. A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO). Oncol Res Treat. 2023;46(3):89-99. |
| Kreimeyer H, Buechter M, Best J, Gieseler RK, Katsounas A, Sowa JP, Gerken G, Canbay A, Manka P, Bechmann LP. Performance of the Liver Maximum Function Capacity Test, Fibrinogen, and Transient Elastography in Patients with Acute Liver Injury. Dig Dis. 2023;41(2):259-267. |
| Maasoumy B, Ingiliz P, Spinner CD, Cordes C, Stellbrink HJ, Schulze Zur Wiesch J, Schneeweiß SM, Deterding K, Müller T, Kahlhöfer J, Dörge P, von Karpowitz M, Manns MP, Wedemeyer H, Cornberg M; HepNet Acute HCV-V Study Group. Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study. JHEP Rep. 2022 Dec 16;5(3):100650. |
| Thimm A, Oubari S, Hoffmann J, Carpinteiro A, Papathanasiou M, Luedike P, Kessler L, Rischpler C, Röcken C, Diebold I, Rassaf T, Schmidt H, Kleinschnitz C, Hagenacker T. A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report. BMC Neurol. 2022 Dec 9;22(1):469. |
| Sinner F, Pinter M, Scheiner B, Ettrich TJ, Sturm N, Gonzalez-Carmona MA, Waidmann O, Finkelmeier F, Himmelsbach V, De Toni EN, Ben Khaled N, Mohr R, Fründt TW, Kütting F, Bömmel FV, Lieb S, Krug S, Bettinger D, Schultheiß M, Jochheim LS, Best J, Müller C, Keitel V, Venerito M. Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers (Basel). 2022 Dec 2;14(23):5966. |
| Li F, Deng Y, Zhang S, Zhu B, Wang J, Wang J, Wang X, Zhao Z, Deng W, Mao R, Shen Z, Chen J, Broering R, Lin Y, Lu M, Zhang J. Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines. Emerg Microbes Infect. 2022 Dec;11(1):616-628. |
| Albers D, Schmidt A, Schiemer M, Caca K, Wannhoff A, Sauer P, Wiesweg M, Schumacher B, Dechêne A. Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents: a randomized controlled multicenter-trial. Gastrointest Endosc. 2022 Dec;96(6):970-979. |
| Oral EA, Garg A, Tami J, Huang EA, O’Dea LSL, Schmidt H, Tiulpakov A, Mertens A, Alexander VJ, Watts L, Hurh E, Witztum JL, Geary RS, Tsimikas S. Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study: Volanesorsen in FPLD; The BROADEN Study. J Clin Lipidol. 2022 Nov-Dec;16(6):833-849. |
| Schmidt M, Yilmaz A, Bietenbeck M, Schilling M, Röcken C, Schmidt HH-J. [de novo hATTR amyloidosis after domino transplantation of a donor’s liver: a case report for the use of Patisiran]. Z Gastroenterol. 2022 Nov;60(11):1659-1664. |
| Bufe S, Zimmermann A, Ravens S, Prinz I, Buitrago-Molina LE, Geffers R, Woller N, Kühnel F, Talbot SR, Noyan F, Manns MP, Wedemeyer H, Hardtke-Wolenski M, Jaeckel E, Davalos-Misslitz AC. PD-1/CTLA-4 Blockade Leads to Expansion of CD8+PD-1int TILs and Results in Tumor Remission in Experimental Liver Cancer. Liver Cancer. 2022 Oct 7;12(2):129-144. |
| Langer MM, Eickelmann C, Kleinbongard P, Lange CM. Impaired mitochondrial complex IV respiration in peripheral blood mononuclear cells discriminates acute-on-chronic liver failure from acute decompensation. J Hepatol. 2022 Sep;77(3):874-876. |
| Thimm A, Carpinteiro A, Oubari S, Papathanasiou M, Luedike P, Kessler L, Rischpler C, Blau T, Reinhardt HC, Rassaf T, Schmidt H, Kleinschnitz C, Hagenacker T. Prevalence and predictors of neurological manifestations in systemic AL amyloidosis. J Neurol Sci. 2022 Sep 15;440:120341. |
| Khera T, Du Y, Todt D, Deterding K, Strunz B, Hardtke S, Aregay A, Port K, Hardtke-Wolenski M, Steinmann E, Björkström NK, Manns MP, Hengst J, Cornberg M, Wedemeyer H; HepNet Acute HCV IV Study Group. Long-lasting Imprint in the Soluble Inflammatory Milieu despite Early Treatment of Acute Symptomatic Hepatitis C. J Infect Dis. 2022 Aug 26;226(3):441-452. |
| Sokolova V, Ebel JF, Kollenda S, Klein K, Kruse B, Veltkamp C, Lange CM, Westendorf AM, Epple M. Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell Models. Small. 2022 Aug;18(31):e2201167. |
| Weiand M, Ballmaier P, Niemietz C, Schmidt H, Zibert A. Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation. Biochem Biophys Rep. 2022 Jul 16;31:101308. |
| Houben P, Bormann E, Kneifel F, Katou S, Morgül MH, Vogel T, Bahde R, Radünz S, Pascher A, Schmidt H, Brockmann JG, Becker F. How Old Is Old? An Age-Stratified Analysis of Elderly Liver Donors above 65. J Clin Med. 2022 Jul 4;11(13):3899. |
| Schmidt HH, Wixner J, Planté-Bordeneuve V, Muñoz-Beamud F, Lladó L, Gillmore JD, Mazzeo A, Li X, Arum S, Jay PY, Adams D; patisiran post-OLT study group. Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation. Am J Transplant. 2022 Jun;22(6):1646-1657. |
| Khera T, Madsen LW, Du Y, Lillevang ST, Christensen PB, Wedemeyer H. Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment. J Viral Hepat. 2022 Jun;29(6):447-454. |
| Schubert S, Picker N, Cavlar T, Knop J, Kahraman A, Mohl W. Inflammatory Bowel Disease Patients‘ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study. Adv Ther. 2022 Jun;39(6):2889-2905. |
| Bokemeyer A, Lenze F, Stoica V, Sensoy TS, Kabar I, Schmidt H, Ullerich H. Digital single-operator video cholangioscopy improves endoscopic management in patients with primary sclerosing cholangitis-a retrospective observational study. World J Gastroenterol. 2022 May 28;28(20):2201-2213. |
| Benkö T, König J, Theysohn JM, Schotten C, Saner FH, Treckmann J, Radunz S. Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization? Eur J Med Res. 2022 May 26;27(1):74. |
| Kühne Escolà J, Theysohn JM, Li Y, Forsting M, Capetian P, Volkmann J, Lange C, Quesada CM, Köhrmann M, Frank B, Kleinschnitz C. Extrahepatic portosystemic shunts as an unusual but treatable cause of hyperammonemic encephalopathy in a noncirrhotic patient – a case report. Ther Adv Neurol Disord. 2022 May 14;15:17562864221097614. |
| Veltkamp C, Lan S, Korompoki E, Weiss KH, Schmidt H, Seitz HK. Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease. J Clin Med. 2022 May 6;11(9):2623. |
| Keimburg SA, Theysohn J, Buechter M, Rashidi-Alavijeh J, Willuweit K, Schneider H, Wetter A, Maasoumy B, Lange C, Wedemeyer H, Markova AA. FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts. Biomedicines. 2022 Apr 28;10(5):1018. |
| Leyh C, Ehmer U, Roessler D, Philipp AB, Reiter FP, Jeliazkova P, Jochheim LS, Jeschke M, Hammig J, Ludwig JM, Theysohn JM, Geier A, Lange CM. Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis. Cancers (Basel). 2022 Apr 13;14(8):1975. |
| Rashidi-Alavijeh J, Frey A, Hörster A, Nguyen BP, Iannaccone A, Saner F, Lange CM, Willuweit K. Safe for Mother, Baby, and Graft? Pregnancy After Liver Transplant: A Single-Center Experience. Transplant Proc. 2022 Apr;54(3):744-748. |
| Ben Khaled N, Seidensticker M, Ricke J, Mayerle J, Oehrle B, Rössler D, Teupser D, Ehmer U, Bitzer M, Waldschmidt D, Fuchs M, Reuken PA, Lange CM, Wege H, Kandulski A, Dechêne A, Venerito M, Berres ML, Luedde T, Kubisch I, Reiter FP, De Toni EN. Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol. Future Oncol. 2022 Apr;18(12):1423-1435. |
| Bulut K, Markova A, Canbay AE, Schmidt WE, Kahraman A. Whipple’s disease – a rare and challenging complication in a patient with Crohn’s disease. Z Gastroenterol. 2022 Apr;60(4):598-601. |
| Mattig I, Heidecker B, Tschöpe C, Messroghli D, Eurich D, Kleefeld F, Gaedeke J, Stenzel W, Schmidt HH, Röcken C, Knebel F, Hahn K. Progressive Hereditary Transthyretin-Related Amyloidosis (ATTRv) Aggravated by ATTR Wild-Type and Complement Activation. J NeuropatholExp Neurol. 2022 Mar 29;81(4):299-303. |
| Dancs PT, Saner FH, Benkö T, Molmenti EP, Büchter M, Paul A, Hoyer DP. Balancing Outcome vs. Urgency in Modern Liver Transplantation. Front Surg. 2022 Mar 4;9:853727. |
| Kahraman A, Gerken G, Christoph S. IgG4-positive Erkrankungen des GITrakts. Verdauungskrankheiten 2022; 40: 69-75. |
| Du Y, Khera T, Strunz B, Deterding K, Todt D, Woller N, Engelskircher SA, Hardtke S, Port K, Ponzetta A, Steinmann E, Cornberg M, Hengst J, Björkström NK, Wedemeyer H; HepNet Acute HCV Ⅳ Study Group. Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment. Eur J Immunol. 2022 Mar;52(3):472-483. |
| Stockhoff L, Muellner-Bucsics T, Markova AA, Schultalbers M, Keimburg SA, Tergast TL, Hinrichs JB, Simon N, Gerbel S, Manns MP, Mandorfer M, Cornberg M, Meyer BC, Wedemeyer H, Reiberger T, Maasoumy B. Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS. Hepatol Commun. 2022 Mar;6(3):621-632. |
| Willuweit K, Frey A, Passenberg M, Korth J, Saka N, Anastasiou OE, Möhlendick B, Schütte A, Schmidt H, Rashidi-Alavijeh J. Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers. Vaccines (Basel). 2022 Feb 28;10(3):377. |
| de Castro T, Jochheim LS, Bathon M, Welland S, Scheiner B, Shmanko K, Roessler D, Khaled NB, Jeschke M, Ludwig JM, Marquardt JU, Weinmann A, Pinter M, Lange CM, Vogel A, Saborowski A. Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience. Ther Adv Med Oncol. 2022 Feb 26;14:17588359221080298. |
| Stoffers P, Guckenbiehl S, Welker MW, Zeuzem S, Lange CM, Trebicka J, Herrmann E, Welsch C. Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation. PLoS One. 2022 Feb 17;17(2):e0263989. |
| Lemmer P, Manka P, Best J, Kahraman A, Kälsch J, Vilchez-Vargas R, Link A, Chiang H, Gerken G, Canbay A, Bechmann LP, Sydor S. Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease. J Clin Med. 2022 Feb 8;11(3):890. |
| Buechter M, Katsounas A, Saner F, Gerken G, Canbay A, Dechêne A. ERCP in critically ill patients is safe and does not increase mortality. Medicine (Baltimore). 2022 Feb 4;101(5):e28606. |
| Li J, Kemper T, Broering R, Chen J, Yuan Z, Wang X and Lu M. Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication. Front Cell Infect Microbiol. 2022 Feb 2;12:804011. |
| Dywicki J, Buitrago-Molina LE, Noyan F, Davalos-Misslitz AC, Hupa-Breier KL, Lieber M, Hapke M, Schlue J, Falk CS, Raha S, Prinz I, Koenecke C, Manns MP, Wedemeyer H, Hardtke-Wolenski M, Jaeckel E. The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis. Hepatol Commun. 2022 Feb;6(2):320-333. |
| Manka P, Sydor S, Schänzer-Ocklenburg JM, Brandenburg M, Best J, Vilchez-Vargas R, Link A, Heider D, Brodesser S, Figge A, Jähnert A, Coombes JD, Cubero FJ, Kahraman A, Kim M-S, Kälsch J, Kinner S, Faber KN, Moshage H, Gerken G, Syn W-K, Canbay A, Bechmann LP. A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver. Metabolites 2022 Jan 30;12(2):130. |
| Senff T, Menne C, Cosmovici C, Lewis-Ximenez LL, Aneja J, Broering R, Kim AY, Westendorf AM, Dittmer U, Scherbaum N, Lauer GM, Timm J. Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C. JCI Insight 2022 Jan 25;7(2):e155432. |
| Werner M, Schefczyk S, Trippler M, Treckmann JW, Baba HA, Gerken G, Schlaak JF, Broering R. Antiviral Toll-like Receptor Signaling in Non-Parenchymal Liver Cells Is Restricted to TLR3. Viruses 2022 Jan 24;14(2):218. |
| Vollenberg R, Tepasse PR, Kühn JE, Hennies M, Strauss M, Rennebaum F, Schomacher T, Boeckel G, Lorentzen E, Bokemeyer A, Nowacki TM. Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2. Biomedicines. 2022 Jan 13;10(1):171. |
| Engelmann C, Herber A, Franke A, Bruns T, Schiefke I, Zipprich A, Zeuzem S, Goeser T, Canbay A, Berg C, Trebicka J, Uschner FE, Chang J, Mueller T, Aehling N, Schmelzle M, Splith K, Lammert F, Lange CM, Sarrazin C, Trautwein C, Manns M, Häussinger D, Pfeiffenberger J, Galle PR, Schmiedeknecht A, Berg T. Granulocyte-Colony Stimulating Factor (G-CSF) to treat acute-on-chronic liver failure, a multicenter randomized trial (GRAFT study). J Hepatol. 2021 Dec;75(6):1346-1354. |
| Zhou T, Lenzen H, Dold L, Bündgens B, Wedemeyer H, Manns MP, Gonzalez-Carmona MA, Strassburg CP, Weismüller TJ. Primary sclerosing cholangitis with moderately elevated serum-IgG4 – characterization and outcome of a distinct variant phenotype. Liver Int. 2021 Dec;41(12):2924-2933. |
| Lempp FA, Roggenbach I, Nkongolo S, Sakin V, Schlund F, Schnitzler P, Wedemeyer H, Le Gal F, Gordien E, Yurdaydin C, Urban S. A Rapid Point-of-Care Test for the Serodiagnosis of Hepatitis Delta Virus Infection. Viruses. 2021 Nov 26;13(12):2371 |
| Schreiter T, Gieseler RK, Vílchez-Vargas R, Jauregui R, Sowa JP, Klein-Scory S, Broering R, Croner RS, Treckmann JW, Link A, Canbay A. Transcriptome-Wide Analysis of Human Liver Reveals Age-Related Differences in the Expression of Select Functional Gene Clusters and Evidence for a PPP1R10-Governed ‘Aging Cascade’. Pharmaceutics 2021 Nov 25, 13(12), 2009. |
| Xie X, Luo J, Broering R, Zhu D, Zhou W, Lu M, Zheng X, Dittmer U, Yang D, Liu J. HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance. Cell Mol Immunol. 2021 Nov;18(11):2572-2574. |
| Manka P, Sydor S, Wase N, Best J, Brandenburg M, Hellbeck A, Schänzer J, Vilchez-Vargas R, Link A, Figge A, Jähnert A, von Arnim U, Coombes JD, Cubero FJ, Kahraman A, Kim MS, Kälsch J, Kinner S, Faber KN, Moshage H, Gerken G, Syn WK, Friedman SL, Canbay A, Bechmann LP. Anti-TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut-derived hormones, and metabolic status. Liver Int. 2021 Nov;41(11):2646-2658. |
| Du Y, Broering R, Li X, Zhang X, Liu J, Yang D, Lu M. In vivo mouse models for hepatitis B virus infection and their application. Front Immunol. 2021 Oct 29;12:766534. |
| Seifert LL, Schindler P, Schoster M, Weller JF, Wilms C, Schmidt HH, Maschmeier M, Masthoff M, Köhler M, Heinzow H, Wildgruber M. Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and Rifaximin. J Clin Med. 2021 Oct 17;10(20):4763. |
| Du Y, Yang X, Li J, Sokolova V, Zou S, Han M, Yan H, Wey K, Lu M, Dittmer U, Yang D, Epple M, Wu J. Delivery of Toll-Like Receptor 3 Ligand Poly(I:C) to the Liver by Calcium Phosphate Nanoparticles Conjugated with an F4/80 Antibody Exerts an Anti-Hepatitis B Virus Effect in a Mouse Model. Acta Biomater. 2021 Oct 1;133:297-307. |
| Manka P, Baba HA, Wedemeyer H, Kahraman A. Diet-refractory NASH in an elderly woman. Gut. 2021 Oct;70(10):1924-1945. |
| Hüppe D, Stoehr A, Buggisch P, Mauss S, Klinker H, Teuber G, Hidde D, Lohmann K, Bondin M, Wedemeyer H. The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real-world data from the German Hepatitis C-Registry (DHC-R). J Viral Hepat. 2021 Oct;28(10):1474-1483. |
| Graf C, Arncken J, Lange CM, Willuweit K, Schattenberg JM, Seessle J, Lang-Meli J, Böttler T, Dietz J, Wetzstein N, Mondorf A, Vermehren J, Rohde G, Zeuzem S, Pathil A. Hepatic sarcoidosis: Clinical characteristics and outcome. JHEP Rep. 2021 Sep 3;3(6):100360. |
| Rosery V, Reis H, Savvatakis K, Kowall B, Stuschke M, Paul A, Dechêne A, Yang J, Zhao B, Borgers A, Kasper S, Schuler M, Cheung PF, Siveke JT. Antitumor immune response is associated with favorable survival in GEP-NEN G3. Endocr Relat Cancer. 2021 Sep 2;28(10):683-693. |
| Hirmas N, Leyh C, Sraieb M, Barbato F, Schaarschmidt BM, Umutlu L, Nader M, Wedemeyer H, Ferdinandus J, Rischpler C, Herrmann K, Costa PF, Lange CM, Weber M, Fendler WP. [68Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma (HCC). J Nucl Med. 2021 Sep 1;62(9):1235-1241. |
| Gabriel MM, Kircheis G, Hardtke S, Markwardt D, Buggisch P, Mix H, Grüngreiff K, Welzel TM, Kälsch J, Hartmann H, Gerbes AL, Karpowitz MV, Seeliger B, Wedemeyer H, Weissenborn K; HepNet HE-Register Study Group. Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study. Eur J Gastroenterol Hepatol. 2021 Sep 1;33(9):1185-1193. |
| Du Y, Anastasiou OE, Strunz B, Scheuten J, Bremer B, Kraft A, Kleinsimglinhaus K, Todt D, Broering R, Hardtke-Wolenski M, Wu J, Yang D, Dittmer U, Lu M, Cornberg M, Björkström NK, Khera T, Wedemeyer H. The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B infection. Liver Int. 2021 Sep;41(9):2046-2058. |
| Paternostro R, Staufer K, Traussnigg S, …, Canbay A, Schlattjan M, …, Mandorfer M, Ferenci P, Trauner M. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease. Hepatol Int. 2021 Aug;15(4):922-933. |
| Placke JM, Rawitzer J, Reis H, Rashidi-Alavijeh J, Livingstone E, Ugurel S, Hadaschik E, Griewank K, Schmid KW, Schadendorf D, Roesch A, Zimmer L. Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition – Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry. Front Oncol. 2021 Aug 11;11:725549. |
| Hild B, Dreier MS, Oh JH, McCulloch JA, Badger JH, Guo J, Thefaine CE, Umarova R, Hall KD, Gavrilova O, Rosshart SP, Trinchieri G, Rehermann B. Neonatal exposure to a wild-derived microbiome protects mice against diet-induced obesity. Nat Metab. 2021 Aug;3(8):1042-1057. |
| Schotten C, Ostertag B, Sowa JP, Manka P, Bechmann LP, Hilgard G, Marquardt C, Wichert M, Toyoda H, Lange CM, Canbay A, Johnson P, Wedemeyer H, Best J. GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients. Pharmaceuticals (Basel). 2021 Jul 27;14(8):735. |
| Scheller L, Hilgard G, Anastasiou O, Dittmer U, Kahraman A, Wedemeyer H, Deterding K. Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients. Medicine (Baltimore). 2021 Jul 16;100(28):e26571. |
| Rashidi-Alavijeh J, Kahraman A, Gerken G, Theysohn JM, Willuweit K, Hoyer DP, Lange CM, Buechter M. Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation. Sci Rep. 2021 Jul 5;11(1):13834. |
| Rashidi-Alavijeh J, Frey A, Passenberg M, Korth J, Zmudzinski J, Anastasiou OE, Saner FH, Jahn M, Lange CM, Willuweit K. Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients-A Single-Center Experience. Vaccines (Basel). 2021 Jul 4;9(7):738. |
| Manka P, Syn WK. NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease. Dig Dis Sci. 2021 Jul;66(7):2147-2148. |
| Finkelmeier F, Scheiner B, Leyh C, Best J, Fründt TW, Czauderna C, Beutel A, Bettinger D, Weiß J, Meischl T, Kütting F, Waldschmidt DT, Radu P, Schultheiß M, Peiffer KH, Ettrich TJ, Weinmann A, Wege H, Venerito M, Dufour JF, Lange CM, Pinter M, Waidmann O. Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort. Liver Cancer. 2021 Jul;10(4):360-369. |
| Buechter M, Gerken G. Evaluation of liver function before and during therapy (Editorial). Hepatoma Res 2021;7:48-53. doi: 10.20517/2394-5079.2021.76. |
| Buitrago-Molina LE, Dywicki J, Noyan F, Schepergerdes L, Pietrek J, Lieber M, Schlue J, Manns MP, Wedemeyer H, Jaeckel E, Hardtke-Wolenski M. Anti-CD20 therapy alters the protein signature in experimental murine AIH, but not exclusively towards regeneration. Cells 2021 Jun 11, 10, 1471. |
| Adamczyk A, Pastille E, Kehrmann J, Vu VP, Geffers R, Wasmer MH, Kasper S, Schuler M, Lange CM, Muggli B, Rau TT, Klein D, Hansen W, Krebs P, Buer J, Westendorf AM. GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancer. Cancer Res. 2021 Jun 1;81(11):2970-2982. |
| Rashidi-Alavijeh J, Crämer JC, Sauter HL, Willuweit K, Straub K, Wedemeyer H, Herzer K. Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant. Transpl Infect Dis. 2021 Jun;23(3):e13553. |
| Rashidi-Alavijeh J, Straub K, Achterfeld A, Wedemeyer H, Willuweit K, Herzer K. Safety and efficacy of tenofovir alafenamide in liver transplant recipients: A single center experience. Transpl Infect Dis. 2021 Jun;23(3):e13522. |
| Aregay A, Engel B, Port K, Vondran FWR, Bremer B, Niehaus C, Khera T, Richter N, Jaeckel E, Cornberg M, Taubert R, Wedemeyer H. Distinct Immune imprints of post-Liver transplantation hepatitis C persist despite viral clearance. Liver Transpl. 2021 Jun;27(6):887-899. |
| Luo X, Zhang R, Lu M, Liu S, Baba HA, Gerken G, Wedemeyer H, Broering R. Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection. Front Immunol. 2021 May 25;12:684424. |
| Figge A, Sydor S, Wenning C, Manka P, Assmuth S, Vilchez-Vargas R, Link A, Jähnert A, Brodesser S, Lucas C, Nevzorova YA, Faber KN, Moshage H, Porsch-Özcürümez M, Gerken G, Cubero FJ, Canbay A, Bechmann LP. Gender and gut microbiota composition determine hepatic bile acid, metabolic and inflammatory response to a single fast-food meal in healthy adults. Clin Nutr. 2021 May;40(5):2609-2619. |
| Krassenburg LAP, Maan R, Ramji A, Manns MP, Cornberg M, Wedemeyer H, de Knegt RJ, Hansen BE, Janssen HLA, de Man RA, Feld JJ, van der Meer AJ. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity. J Hepatol. May;74(5):1053-1063. |
| Owusu Sekyere S, Port K, Deterding K, Cornberg M, Wedemeyer H. Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients. United European Gastroenterol J. 2021 May;9(4):486-496. |
| Best J, Gerken G. The narrow ridge from liver damage to hepatocarcino-genesis. Hepatoma Res. 2021;7:32. |
| Tegtmeyer B, Vieyres G, Todt D, Lauber C, Ginkel C, Engelmann M, Herrmann M, Pfaller CK, Vondran FWR, Broering R, Vafadarnejad E, Saliba AE, Puff C, Baumgärtner W, Miskey C, Ivics Z, Steinmann E, Pietschmann T, Brown RJP. Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elements. J Virol. 2021 Apr 26;95(10):e00245-21. |
| Zhu AX, Finn RS, Kang YK, Yen CJ, Galle PR, Llovet JM, Assenat E, …, Vogel A, Yamashita T, Hsu CH, Gerken G, Bilbruck J, …, Abada P, Kudo M. Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab. Br J Cancer. 2021 Apr;124(8):1388-1397. |
| Ringe KI, Vo Chieu VD, Wacker F, Lenzen H, Manns MP, Hundt C, Schmidt B, Winther HB. Fully automated detection of primary sclerosing cholangitis (PSC)-compatible bile duct changes based on 3D magnetic resonance cholangiopancreatography using machine learning. Eur Radiol. 2021 Apr;31(4):2482-2489. |
| Hupa-Breier KL, Dywicki J, Hartleben B, Wellhöner F, Heidrich B, Taubert R, Mederacke YE, Lieber M, Iordanidis K, Manns MP, Wedemeyer H, Hardtke-Wolenski M, Jaeckel E. Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH. Biomedicines. 2021 Mar 30;9(4):353. |
| Simon KG, Serfert Y, Buggisch P, Mauss S, Boeker KHW, Klinker H, Müller T, Merle U, Hüppe D, Manns MP, Wedemeyer H. [Evolution of hepatitis C virus genotype 1a vs. 1b distribution in Germany between 2004 and 2018 – An analysis of 17093 patients from different real world registries]. Z Gastroenterol. 2021 Mar;59(3):241-249. |
| Du Y, Yan H, Zou S, Khera T, Li J, Han M, Yang X, Wang B, Liu J, Sun S, Zheng X, Dittmer U, Lu M, Yang D, Wedemeyer H, Wu J. Natural Killer Cells Regulate the Maturation of Liver Sinusoidal Endothelial Cells Thereby Promoting Intrahepatic T-Cell Responses in a Mouse Model. Hepatol Commun. 2021 Feb 5;5(5):865-881. |
| Markova AA, Deterding K, Port K, Bantel H, Manns MP, Cornberg M, Wedemeyer H. Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort. Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):223-229. |
| Broering R, Luo X, Liu J, Lu M. Controversial: Early Innate Responses to Hepatitis B Virus Infection, an Explanation for Viral Persistence? Virol Sin. 2021 Feb;36(1):163-166. |
| Wetter A, Willuweit K, Haubold J, Theysohn J. Endovaskuläre Behandlung einer arterio-portalvenösen Fistel nach TIPS-Anlage bei Budd-Chiari-Syndrom. Rofo. 2021 Feb;193(2):194-195. |
| Buitrago-Molina LE, Pietrek J, Noyan F, Schlue J, Manns MP, Wedemeyer H, Hardtke-Wolenski M, Jaeckel E. Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis. J Autoimmun. 2021 Feb;117:102591. |
| Anastasiou OE, Yurdaydin C, Maasoumy B, Hardtke S, Caruntu FA, Curescu MG, Yalcin K, Akarca US, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Radu M, Liebig S, Bantel H, Bremer B, Manns MP, Cornberg M, Wedemeyer H. A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction. J Viral Hepat. 2021 Feb;28(2):410-419. |
| Bremer B, Anastasiou OE, Hardtke S, Caruntu FA, Curescu MG, Yalcin K, Akarca US, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Radu M, Idilman R, Manns MP, Cornberg M, Yurdaydin C, Wedemeyer H. Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study. Liver Int. 2021 Feb;41(2):295-299. |
| Markova A, Wedemeyer H. [Statin use in patients with liver disease – overview and results from a retrospektive observational study]. MMW Fortschr Med. 2021 Feb;163(3):74-77. |
| Rueschenbaum S, Ciesek S, Queck A, Widera M, Schwarzkopf K, Brüne B, Welsch C, Wedemeyer H, Zeuzem S, Weigert A, Lange CM. Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure. Front Immunol. 2021 Jan 26;11:534731. |
| Gliga S, Fiedler M, Dornieden T, Achterfeld A, Paul A, Horn PA, Herzer K, Lindemann M. Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients. Vaccines (Basel). 2021 Jan 25;9(2):88. |
| Rueschenbaum S, Cai C, Schmidt M, Schwarzkopf K, Dittmer U, Zeuzem S, Welsch C, Lange CM. Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic Immunity. Front Immunol. 2021 Jan 14;11:581352. |
| Dauth N, Mücke VT, Mücke MM, Lange CM, Welker M, Zeuzem S, Badenhoop K. Hypopituitarism in Wilson’s disease resolved after copper-chelating therapy. Endocrinol Diabetes Metab Case Rep. 2021 Jan 11;2021:EDM200086. doi: 10.1530/EDM-20-0086. Online ahead of print. |
| Buitrago-Molina LE, Dywicki J, Noyan F, Trippler M, Pietrek J, Schlue J, Manns MP, Wedemeyer H, Jaeckel E, Hardtke-Wolenski M. Splenectomy Prior to Experimental Induction of Autoimmune Hepatitis Promotes More Severe Hepatic Inflammation, Production of IL-17 and Apoptosis. Biomedicines. 2021 Jan 9;9(1):58. |
| Zhou L, He R, Fang P, Li M, Yu H, Wang Q, Yu Y, Wang F, Zhang Y, Chen A, Peng N, Lin Y, Zhang R, Trilling M, Broering R, Lu M, Zhu Y, Liu S. Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition. Nat Commun. 2021 Jan 4;12(1):98. |
| Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, …, Buitrago-Molina LE, …, Sluimer JC, Stallings CL, Tong CK. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021 Jan;17(1):1-382. |
| Anastasiou OE, Lange CM. Response to the Letter: Impact of SARS-CoV-2 Infection on Patients Suffering from Liver Injury. Dig Dis. 2021;39(1):68-69. |
| Anastasiou OE, Korth J, Herbstreit F, Witzke O, Lange CM. Mild versus Severe Liver Injury in SARS-CoV-2 Infection. Dig Dis. 2021;39(1):52-57. |